UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

UCP2 Deficiency Renders Th1/2 Pathogenic Phenotype to CD4+ T cells

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.64-64.11

2023

Volltextzugriff (PDF)

Hydrogen sulfide signaling in promoting the anti-tumor T cell response

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.119-119.09

2022

Volltextzugriff (PDF)

Modulating the ER and Golgi stress response in T cells with hydrogen sulfide signaling to enhance the anti-tumor immune response

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.68-68.11

2023

Volltextzugriff (PDF)

IL-12 alters T-cell metabolism to augment anti-tumor immunotherapy

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.143-143.07

2023

Volltextzugriff (PDF)

Targeting Autophagy with Carbon-monoxide Reprograms Anti-Tumor T Cells with Robust Immunometabolic Phenotype

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.117-117.18

2022

Volltextzugriff (PDF)

Higher antioxidant capacity determines the survival of class I restricted antigen specific CD4 T cells in comparison to CD8 T cells (52.20)

The Journal of immunology (1950), 2012-05, Vol.188 (1_Supplement), p.52-52.20

2012

Volltextzugriff (PDF)

Sphingosine 1-phosphate / Acetyl CoA Carboxylase1 Axis regulates the Differentiation and Function of Tumor-associated Myeloid-Derived Suppressor Cells

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.157-157.08

2023

Volltextzugriff (PDF)

Targeting Sphingosine kinase 2/S1P axis Decreases Immunosuppressive Potential of Myeloid Derived Suppressor Cells (MDSCs) and Improves Tumor Control

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.205-205.16

2017

Volltextzugriff (PDF)

Suboptimal ER stress Induced Autophagy Potentiates Anti-tumor T Cell Response

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.137-137.5

2019

Volltextzugriff (PDF)

Metabolic Reprograming of Alloantigen-Activated T Cells after Hematopoietic Cell Transplantation

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.140-140.12

2016

Volltextzugriff (PDF)

SphK1/S1P Axis Regulate PPARγ Levels to Program Metabolically Fit Anti-Tumor T Cells

The Journal of immunology (1950), 2018-05, Vol.200 (1_Supplement), p.179-179.9

2018

Volltextzugriff (PDF)

Autophagy Induced due to Moderate Endoplasmic Reticulum Stress in T Cells Enhances Immunotherapeutic Tumor Control

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.162-162.14

2020

Volltextzugriff (PDF)

S1P/PPARγ axis metabolically reprograms the T cells to modulate their anti-tumor potential

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.198-198.8

2017

Volltextzugriff (PDF)

Anti-tumor response in T cells with CD8 independent high affinity TCR remains unaffected with aging (VAC11P.1009)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.205-205.10

2014

Volltextzugriff (PDF)

Lack of p53 augments anti-tumor functions of cytolytic T cells (VAC11P.1005)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.205-205.6

2014

Volltextzugriff (PDF)

Increased expression of anti-oxidant molecule Thioredoxin-1 on T cells improves immunotherapeutic control of tumors (VAC7P.1039)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.143-143.9

2015

Volltextzugriff (PDF)

Rescuing CTLs from undergoing TCR restimulation induced necroptosis improves tumor control (VAC7P.1034)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.143-143.4

2015

Volltextzugriff (PDF)

Induction of cell death following restimulation of the T cell receptor results in activation of the DNA damage response pathway in a JNK and ROS-dependent manner (TUM7P.1026)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.142-142.15

2015

Volltextzugriff (PDF)

Increasing Th1 phenotype in Th17 cells improves anti-tumor T cells function (VAC7P.1032)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.143-143.2

2015

Volltextzugriff (PDF)

rhIL-15 and rhIL-2 together enhances growth and function of TCR transduced T cells for adoptive immunotherapy (P4358)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.177-177.12

2013

Volltextzugriff (PDF)

The inducible costimulator augments Tc17 cell responses to self and tumor tissue

The Journal of immunology (1950), 2015-02, Vol.194 (4), p.1737-1747

2015

Volltextzugriff (PDF)

Hybrid Th1/17 cells possess unique immuno-metabolic phenotype and surpiror anti-tumor activity

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.214-214.18

2016

Volltextzugriff (PDF)

Sphingosine kinase 1 and its role in modulation of anti-tumor T-cell responses (VAC3P.951)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.73-73.13

2014

Volltextzugriff (PDF)

Reduced ectonucleotidase expression on TGF-β independent Th17 improves tumor control (VAC11P.1006)

The Journal of immunology (1950), 2014-05, Vol.192 (1_Supplement), p.205-205.7

2014

Volltextzugriff (PDF)

Low signal strength enhances the antitumor activity of human CAR Th17 cells

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.143-143.2

2016

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaCell Biology

Zeitschrift / SerieThe Journal Of Immunology

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(42)

Erscheinungsjahr

n.n

Kollektion

Zeitschrift / Serie

The journal Of Immunology/the journal Of Immunology
(9)

Menü

Weitere Dienste

Einstellungen

UCP2 Deficiency Renders Th1/2 Pathogenic Phenotype to CD4+ T cells

Hydrogen sulfide signaling in promoting the anti-tumor T cell response

Modulating the ER and Golgi stress response in T cells with hydrogen sulfide signaling to enhance the anti-tumor immune response

IL-12 alters T-cell metabolism to augment anti-tumor immunotherapy

Targeting Autophagy with Carbon-monoxide Reprograms Anti-Tumor T Cells with Robust Immunometabolic Phenotype

Higher antioxidant capacity determines the survival of class I restricted antigen specific CD4 T cells in comparison to CD8 T cells (52.20)

Sphingosine 1-phosphate / Acetyl CoA Carboxylase1 Axis regulates the Differentiation and Function of Tumor-associated Myeloid-Derived Suppressor Cells

Targeting Sphingosine kinase 2/S1P axis Decreases Immunosuppressive Potential of Myeloid Derived Suppressor Cells (MDSCs) and Improves Tumor Control

Suboptimal ER stress Induced Autophagy Potentiates Anti-tumor T Cell Response

Metabolic Reprograming of Alloantigen-Activated T Cells after Hematopoietic Cell Transplantation

SphK1/S1P Axis Regulate PPARγ Levels to Program Metabolically Fit Anti-Tumor T Cells

Autophagy Induced due to Moderate Endoplasmic Reticulum Stress in T Cells Enhances Immunotherapeutic Tumor Control

S1P/PPARγ axis metabolically reprograms the T cells to modulate their anti-tumor potential

Anti-tumor response in T cells with CD8 independent high affinity TCR remains unaffected with aging (VAC11P.1009)

Lack of p53 augments anti-tumor functions of cytolytic T cells (VAC11P.1005)

Increased expression of anti-oxidant molecule Thioredoxin-1 on T cells improves immunotherapeutic control of tumors (VAC7P.1039)

Rescuing CTLs from undergoing TCR restimulation induced necroptosis improves tumor control (VAC7P.1034)

Induction of cell death following restimulation of the T cell receptor results in activation of the DNA damage response pathway in a JNK and ROS-dependent manner (TUM7P.1026)

Increasing Th1 phenotype in Th17 cells improves anti-tumor T cells function (VAC7P.1032)

rhIL-15 and rhIL-2 together enhances growth and function of TCR transduced T cells for adoptive immunotherapy (P4358)

The inducible costimulator augments Tc17 cell responses to self and tumor tissue

Hybrid Th1/17 cells possess unique immuno-metabolic phenotype and surpiror anti-tumor activity

Sphingosine kinase 1 and its role in modulation of anti-tumor T-cell responses (VAC3P.951)

Reduced ectonucleotidase expression on TGF-β independent Th17 improves tumor control (VAC11P.1006)

Low signal strength enhances the antitumor activity of human CAR Th17 cells

Aktive Filter

Suchergebnisse filtern